TOIIW — The Oncology Institute Inc
NASDAQ
$0.05
+$0.00 (+0.00%)
The Oncology Institute Inc (TOIIW) common stock listed on NASDAQ. It is led by Daniel Virnich FACHE, M.B.A., M.D., based in 18000 Studebaker Road, Cerritos, CA, United States, 90703, with about 641 employees. The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Latest reported TOIIW revenue for 2025-09-30 was $136.6M. Net income was -$16.5M. Revenue was up 14.0% from 2025-06-30 to 2025-09-30.
Use this TOIIW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TOIIW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TOIIW SEC filings page. Lician reads the product cache first so this HTML stays unique to The Oncology Institute Inc even when a live quote feed is slow.
About The Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
TOIIW Key Statistics
Market Cap
$0.00M
Volume
5
Previous Close
$0.05
Day Range
$0.05 – $0.05
EPS
-$0.71
Revenue
$393.41M
Net Income
-$64.66M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+21.3%
Profit Margin
-16.4%
Employees
641
TOIIW Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $393.41M | $324.24M | $252.48M | $203.00M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$64.66M | -$83.07M | $152.00K | -$10.93M |
| EPS (Diluted) | -$0.71 | -$0.92 | -$0.21 | -$0.16 |
Total Assets
$172.72M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$0.00
Operating Cash Flow
$4.00M
Free Cash Flow
$0.00
The Oncology Institute Inc Company Information
- CEO & Executive Director
- Daniel Virnich FACHE, M.B.A., M.D.
- Headquarters
- 18000 Studebaker Road, Cerritos, CA, United States, 90703
- Website
- theoncologyinstitute.com
- Phone
- 562 735 3226
- IPO / Founded
- 2020-06-04